Dan A. Landau, MD, PhD

Dan is a core faculty member at the New York Genome Center.  He is also an Associate Professor of Medicine at Weill Cornell Medicine.  Previously, he was an instructor of medicine at Harvard Medical School.

Dan’s goal is to devise therapies that directly anticipate and address tumor evolution.  He pioneered the study of intratumoral genetic and epigenetic diversity in patient samples to understand cancer evolution in its natural environment.

Dan has received multiple awards, including the 2019 Weill Cornell Department of Medicine Young Investigators Award, a 2018 NIH Director’s New Innovator Award, an ASPIRE Award from The Mark Foundation for Cancer Research, a Stand Up to Cancer Philip A. Sharp Innovation in Collaboration Award, and a Lung Cancer Discovery Award from the American Lung Association.  Dan obtained his MD from Tel Aviv University. He then went on to receive his PhD from Paris Diderot University.